Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CEZAR ILIESCU and JUAN LOPEZ-MATTEI.
CEZAR ILIESCU
Connection Strength
11.189
JUAN LOPEZ-MATTEI
  1. Skip Soft Definitions and Focus on Hard?Endpoints. JACC CardioOncol. 2019 Dec; 1(2):218-220.
    View in: PubMed
    Score: 0.710
  2. Editorial Commentary: Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities. Trends Cardiovasc Med. 2019 01; 29(1):40.
    View in: PubMed
    Score: 0.640
  3. Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the "forgotten pulmonic valve". Front Cardiovasc Med. 2022; 9:1071138.
    View in: PubMed
    Score: 0.221
  4. Bioprosthetic valve monitoring in patients with carcinoid heart disease. Front Cardiovasc Med. 2022; 9:1072890.
    View in: PubMed
    Score: 0.220
  5. Trigger related outcomes of takotsubo syndrome in a cancer population. Front Cardiovasc Med. 2022; 9:1019284.
    View in: PubMed
    Score: 0.216
  6. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography?(SCCT). Endorsed by the International Cardio-Oncology Society (ICOS). J Cardiovasc Comput Tomogr. 2023 Jan-Feb; 17(1):66-83.
    View in: PubMed
    Score: 0.215
  7. Reclassification of Treatment Strategy with Fractional Flow Reserve in Cancer Patients with Coronary Artery Disease. Medicina (Kaunas). 2022 Jul 01; 58(7).
    View in: PubMed
    Score: 0.212
  8. Fractional Flow Reserve Cardio-Oncology Effects on Inpatient Mortality, Length of Stay, and Cost Based on Malignancy Type: Machine Learning Supported Nationally Representative Case-Control Study of 30 Million Hospitalizations. Medicina (Kaunas). 2022 Jun 28; 58(7).
    View in: PubMed
    Score: 0.212
  9. Predictors of Recurrence and Survival in Cancer Patients With Pericardial Effusion Requiring Pericardiocentesis. Front Cardiovasc Med. 2022; 9:916325.
    View in: PubMed
    Score: 0.210
  10. Percutaneous Coronary Intervention in Patients With Gynecological Cancer: Machine Learning-Augmented Propensity Score Mortality and Cost Analysis for 383,760 Patients. Front Cardiovasc Med. 2021; 8:793877.
    View in: PubMed
    Score: 0.206
  11. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Front Cardiovasc Med. 2021; 8:734820.
    View in: PubMed
    Score: 0.202
  12. How to Perform Pericardiocentesis in Cancer Patients With Thrombocytopenia: A Single-Center Experience. JACC CardioOncol. 2021 Sep; 3(3):452-456.
    View in: PubMed
    Score: 0.198
  13. Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis. Front Cardiovasc Med. 2021; 8:626414.
    View in: PubMed
    Score: 0.197
  14. TAVR and cancer: machine learning-augmented propensity score mortality and cost analysis in over 30 million patients. Cardiooncology. 2021 Jun 28; 7(1):25.
    View in: PubMed
    Score: 0.197
  15. Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy. Eur J Heart Fail. 2021 10; 23(10):1725-1735.
    View in: PubMed
    Score: 0.197
  16. Coronary Stent Healing in Cancer Patients-An Optical Coherence Tomography Perspective. Front Cardiovasc Med. 2021; 8:665303.
    View in: PubMed
    Score: 0.197
  17. Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis. 2021 Jun 01; 32(4):295-301.
    View in: PubMed
    Score: 0.196
  18. Prognostic Factors and Overall Survival After Pericardiocentesis in Patients With Cancer and Thrombocytopenia. Front Cardiovasc Med. 2021; 8:638943.
    View in: PubMed
    Score: 0.195
  19. Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer Patients. Front Cardiovasc Med. 2021; 8:620857.
    View in: PubMed
    Score: 0.194
  20. How to Diagnose and Manage QT?Prolongation in Cancer Patients. JACC CardioOncol. 2021 Mar; 3(1):145-149.
    View in: PubMed
    Score: 0.193
  21. QT Prolongation in Cancer Patients. Front Cardiovasc Med. 2021; 8:613625.
    View in: PubMed
    Score: 0.193
  22. Lenalidomide-Induced Myocarditis, Rare?But Possibly Fatal Toxicity of a Commonly Used Immunotherapy. JACC Case Rep. 2020 Nov; 2(13):2095-2100.
    View in: PubMed
    Score: 0.187
  23. Opportunities for improved cardiovascular disease prevention in oncology patients. Curr Opin Cardiol. 2020 09; 35(5):531-537.
    View in: PubMed
    Score: 0.186
  24. Transcatheter and surgical aortic valve replacement impact on outcomes and cancer treatment schedule. Int J Cardiol. 2021 03 01; 326:62-70.
    View in: PubMed
    Score: 0.186
  25. Cardiovascular Complications of Chimeric Antigen Receptor T-Cell Therapy: The Cytokine Release Syndrome and Associated Arrhythmias. J Immunother Precis Oncol. 2020 Aug; 3(3):113-120.
    View in: PubMed
    Score: 0.185
  26. Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol. 2020 08 15; 313:1-8.
    View in: PubMed
    Score: 0.182
  27. Halloween in the Cath Lab: spider web pericardial effusion. Eur Heart J Cardiovasc Imaging. 2020 03 01; 21(3):317.
    View in: PubMed
    Score: 0.180
  28. Prevalence of pulmonary hypertension in myelofibrosis. Ann Hematol. 2020 Apr; 99(4):781-789.
    View in: PubMed
    Score: 0.180
  29. Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography. Front Cardiovasc Med. 2020; 7:9.
    View in: PubMed
    Score: 0.179
  30. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy. Cardiovasc Pathol. 2020 Jul - Aug; 47:107211.
    View in: PubMed
    Score: 0.179
  31. Cardiac Interventional Procedures in Cardio-Oncology Patients. Cardiol Clin. 2019 Nov; 37(4):469-486.
    View in: PubMed
    Score: 0.176
  32. Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy. J Cardiovasc Imaging. 2019 Oct; 27(4):268-279.
    View in: PubMed
    Score: 0.175
  33. The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics. Methodist Debakey Cardiovasc J. 2019 Oct-Dec; 15(4):258-266.
    View in: PubMed
    Score: 0.175
  34. Fulminant Vascular and Cardiac Toxicity Associated with Tyrosine Kinase Inhibitor Sorafenib. Cardiovasc Toxicol. 2019 08; 19(4):382-387.
    View in: PubMed
    Score: 0.173
  35. The Onco-cardiologist Dilemma: to Implant, to Defer, or to Avoid Transcatheter Aortic Valve Replacement in Cancer Patients with Aortic Stenosis? Curr Cardiol Rep. 2019 07 08; 21(8):83.
    View in: PubMed
    Score: 0.172
  36. Cardiac toxicities of anticancer treatments: chemotherapy, targeted therapy and immunotherapy. Curr Opin Cardiol. 2019 07; 34(4):441-450.
    View in: PubMed
    Score: 0.172
  37. Refractory radiation-induced coronary artery disease: mapping the path and guiding treatment with optical coherence tomography. Int J Cardiovasc Imaging. 2019 May; 35(5):759-760.
    View in: PubMed
    Score: 0.167
  38. Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. Am J Cardiol. 2019 04 15; 123(8):1351-1357.
    View in: PubMed
    Score: 0.167
  39. An update on the management and outcomes of cancer patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2019 09 01; 94(3):438-445.
    View in: PubMed
    Score: 0.166
  40. The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment. Oncol Lett. 2019 May; 17(5):4126-4132.
    View in: PubMed
    Score: 0.165
  41. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open Heart. 2018; 5(2):e000881.
    View in: PubMed
    Score: 0.163
  42. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients With Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol. 2018 11 01; 122(9):1465-1470.
    View in: PubMed
    Score: 0.161
  43. In Search of a Less Invasive Approach to Cardiac Tumor Diagnosis: Multimodality Imaging Assessment and Biopsy. JACC Cardiovasc Imaging. 2018 08; 11(8):1191-1195.
    View in: PubMed
    Score: 0.161
  44. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. Front Cardiovasc Med. 2018; 5:48.
    View in: PubMed
    Score: 0.159
  45. Evaluation and Management of Cardiac Tumors. Curr Treat Options Cardiovasc Med. 2018 Mar 20; 20(4):29.
    View in: PubMed
    Score: 0.157
  46. Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo's cardiomyopathy. Eur Heart J Case Rep. 2017 Dec; 1(2):ytx006.
    View in: PubMed
    Score: 0.153
  47. Stress-Induced Cardiomyopathy in Cancer Patients. Am J Cardiol. 2017 Dec 15; 120(12):2284-2288.
    View in: PubMed
    Score: 0.152
  48. "Bringing on the light" in a complex clinical scenario: Optical coherence tomography-guided discontinuation of antiplatelet therapy in cancer patients with coronary artery disease (PROTECT-OCT registry). Am Heart J. 2017 Dec; 194:83-91.
    View in: PubMed
    Score: 0.151
  49. The role of cardiac MRI in cardio-oncology. Future Cardiol. 2017 07; 13(4):311-316.
    View in: PubMed
    Score: 0.149
  50. Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15.
    View in: PubMed
    Score: 0.149
  51. Ischemic Heart Disease: Special Considerations in Cardio-Oncology. Curr Treat Options Cardiovasc Med. 2017 May; 19(5):37.
    View in: PubMed
    Score: 0.148
  52. Takotsubo Stress Cardiomyopathy: "Good News" in Cancer Patients? J Am Coll Cardiol. 2016 09 06; 68(10):1143-4.
    View in: PubMed
    Score: 0.141
  53. Stress cardiomyopathy in hospitalized patients with cancer: machine learning analysis by primary malignancy type. ESC Heart Fail. 2021 12; 8(6):4626-4634.
    View in: PubMed
    Score: 0.050
  54. Interventional Strategies in Cancer-induced Cardiovascular Disease. Curr Oncol Rep. 2021 09 27; 23(11):133.
    View in: PubMed
    Score: 0.050
  55. Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management. Korean Circ J. 2021 Jul; 51(7):579-597.
    View in: PubMed
    Score: 0.049
  56. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity. Adv Exp Med Biol. 2021; 1342:377-387.
    View in: PubMed
    Score: 0.048
  57. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. J Am Heart Assoc. 2020 01 21; 9(2):e013757.
    View in: PubMed
    Score: 0.045
  58. Management strategies and clinical outcomes of acute myocardial infarction in leukaemia patients: Nationwide insights from United States?hospitalisations. Int J Clin Pract. 2020 May; 74(5):e13476.
    View in: PubMed
    Score: 0.045
  59. Immune Checkpoint Inhibitors (ICIs)-Related Cardiotoxicity. Adv Exp Med Biol. 2020; 1244:277-285.
    View in: PubMed
    Score: 0.044
  60. Carcinoid Heart Disease: a Comprehensive Review. Curr Cardiol Rep. 2019 11 19; 21(11):140.
    View in: PubMed
    Score: 0.044
  61. Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). Am J Cardiol. 2019 10 15; 124(8):1190-1197.
    View in: PubMed
    Score: 0.043
  62. Multimodality imaging in carcinoid heart disease. Open Heart. 2019; 6(1):e001060.
    View in: PubMed
    Score: 0.043
  63. Applications of Cardiac Computed Tomography in the Cardio-Oncology Population. Curr Treat Options Oncol. 2019 05 06; 20(6):47.
    View in: PubMed
    Score: 0.043
  64. A Cancer Paradox: Machine-Learning Backed Propensity-Score Analysis of Coronary Angiography Findings in Cardio-Oncology. J Invasive Cardiol. 2019 01; 31(1):21-26.
    View in: PubMed
    Score: 0.042
  65. Cardiovascular manifestations of Erdheim-Chester disease. Echocardiography. 2019 02; 36(2):229-236.
    View in: PubMed
    Score: 0.041
  66. Aspergillus endocarditis of the mitral valve with ventricular myocardial invasion, cerebral vasculitis, and intracranial mycotic aneurysm formation in a patient with hemophagocytic lymphohistiocytosis. Med Mycol Case Rep. 2018 Sep; 21:49-51.
    View in: PubMed
    Score: 0.040
  67. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018 02 08; 20(2):10.
    View in: PubMed
    Score: 0.039
  68. Carcinoid heart disease. Heart. 2017 10; 103(19):1488-1495.
    View in: PubMed
    Score: 0.037
  69. Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation. Pulm Circ. 2016 Dec; 6(4):611-613.
    View in: PubMed
    Score: 0.036
  70. Cardiac amyloidosis. Expert Rev Cardiovasc Ther. 2014 Feb; 12(2):265-77.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.